デフォルト表紙
市場調査レポート
商品コード
1089739

ゲノミクスにおけるAI(人工知能)の世界市場:製品別、技術別、機能別、用途別、エンドユーザー別、地域別、2027年までの予測 - COVID-19の累積的影響

Artificial Intelligence In Genomics Market Research Report by Offering, Technology, Functionality, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 200 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
ゲノミクスにおけるAI(人工知能)の世界市場:製品別、技術別、機能別、用途別、エンドユーザー別、地域別、2027年までの予測 - COVID-19の累積的影響
出版日: 2022年06月15日
発行: 360iResearch LLP
ページ情報: 英文 200 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のゲノミクスにおけるAI(人工知能)の市場規模は、32.23%のCAGRで推移し、2027年までに17億1,749万米ドルに達すると予測されています。

当レポートでは、世界のゲノミクスにおけるAI(人工知能)市場について調査し、市場の促進要因、抑制要因、市場機会、課題、製品別・技術別・機能別・用途別・エンドユーザー別・地域別の市場分析、競合情勢、企業プロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーション・範囲
  • 調査対象期間
  • 通貨・価格
  • 言語
  • 制限事項
  • 前提条件
  • 利害関係者

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の累積的影響

第6章 ゲノミクスにおけるAI(人工知能)市場:製品別

  • サービス
  • ソフトウェア

第7章 ゲノミクスにおけるAI(人工知能)市場:技術別s

  • コンピュータビジョン
  • 機械学習

第8章 ゲノミクスにおけるAI(人工知能)市場:機能性別

  • 臨床ワークフロー
  • 遺伝子編集
  • ゲノムシーケンス
  • 予測的遺伝子検査・予防医学

第9章 ゲノミクスにおけるAI(人工知能)市場:用途別

  • 農業・動物研究
  • 診断
  • 創薬・開発
  • その他
  • プレシジョンメディシン

第10章 ゲノミクスにおけるAI(人工知能)市場:エンドユーザー別

  • 政府機関
  • 医療機関
  • その他
  • 製薬・バイオ技術企業
  • 研究センター・学術機関

第11章 南北アメリカのゲノミクスにおけるAI(人工知能)市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋のゲノミクスにおけるAI(人工知能)市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ

第13章 欧州、中東・アフリカのゲノミクスにおけるAI(人工知能)市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品満足度
  • 市場ランキング分析
  • 市場シェア分析:主要企業別
  • 競合シナリオ
    • 合併・買収
    • 合意・コラボレーション・パートナーシップ
    • 新製品の発売・強化
    • 投資・資金調達
    • 評価・認知・拡大

第15章 企業のユーザビリティプロファイル

  • BenevolentAI Ltd.
  • Cambridge Cancer Genomics
  • Data4Cure Inc.
  • Deep Genomics Inc.
  • DNAnexus Inc.
  • Eli Lilly and Company
  • Engine Biosciences Pte. Ltd.
  • Fabric Genomics Inc.
  • FDNA Inc.
  • Freenome Holdings, Inc.
  • Genoox Ltd.
  • International Business Machines Corporation
  • Invitae Corporation
  • Lifebit Biotech
  • Microsoft Corporation
  • MolecularMatch, Inc.
  • NVIDIA Corporation
  • PrecisionLife Ltd.
  • SOPHiA GENETICS
  • Verge Genomics

第16章 付録

  • ディスカッションガイド
  • ライセンス・価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: DYNAMICS
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2021 VS 2027 (%)
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2021 VS 2027 (USD MILLION)
  • FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2027
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICES, 2019-2027 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE, 2019-2027 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2027
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COMPUTER VISION, 2019-2027 (USD MILLION)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COMPUTER VISION, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2019-2027 (USD MILLION)
  • FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTIONALITY, 2021 VS 2027 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTIONALITY, 2021 VS 2027 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTIONALITY, 2027
  • FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL WORKFLOWS, 2019-2027 (USD MILLION)
  • FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL WORKFLOWS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENE EDITING, 2019-2027 (USD MILLION)
  • FIGURE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENE EDITING, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENOME SEQUENCING, 2019-2027 (USD MILLION)
  • FIGURE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENOME SEQUENCING, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, 2019-2027 (USD MILLION)
  • FIGURE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
  • FIGURE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2027
  • FIGURE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, 2019-2027 (USD MILLION)
  • FIGURE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2019-2027 (USD MILLION)
  • FIGURE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2019-2027 (USD MILLION)
  • FIGURE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHER, 2019-2027 (USD MILLION)
  • FIGURE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHER, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2019-2027 (USD MILLION)
  • FIGURE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
  • FIGURE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
  • FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2027
  • FIGURE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, 2019-2027 (USD MILLION)
  • FIGURE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2019-2027 (USD MILLION)
  • FIGURE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHERS, 2019-2027 (USD MILLION)
  • FIGURE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHERS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, 2019-2027 (USD MILLION)
  • FIGURE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH CENTERS, ACADEMIC INSTITUTES, &, 2019-2027 (USD MILLION)
  • FIGURE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH CENTERS, ACADEMIC INSTITUTES, &, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 53. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 54. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 55. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 56. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 57. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 58. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 59. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 60. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 61. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 62. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 63. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 64. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 65. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 66. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 67. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 68. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 69. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 70. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 71. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 72. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 73. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 74. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 75. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 76. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 77. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 78. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 79. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 80. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 81. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 82. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: SHARE, BY KEY PLAYER, 2021
  • FIGURE 85. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2019-2027 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 5. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 6. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 7. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 8. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 10. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 11. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 12. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 13. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COMPUTER VISION, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COMPUTER VISION, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 21. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 22. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 23. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTIONALITY, 2019-2027 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL WORKFLOWS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 27. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL WORKFLOWS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 28. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL WORKFLOWS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL WORKFLOWS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 30. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL WORKFLOWS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENE EDITING, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 32. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 33. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENE EDITING, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 35. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENOME SEQUENCING, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 37. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENOME SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 38. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENOME SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENOME SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 40. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENOME SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 42. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 43. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 45. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 48. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 49. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 51. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 53. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 54. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 58. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 59. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHER, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 63. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHER, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 64. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHER, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHER, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHER, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 68. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 69. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 74. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 75. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 79. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 80. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHERS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 84. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 85. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHERS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 89. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 90. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH CENTERS, ACADEMIC INSTITUTES, &, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 94. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH CENTERS, ACADEMIC INSTITUTES, &, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 95. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH CENTERS, ACADEMIC INSTITUTES, &, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH CENTERS, ACADEMIC INSTITUTES, &, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH CENTERS, ACADEMIC INSTITUTES, &, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 98. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 99. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 100. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 101. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 102. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 103. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 105. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 106. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 107. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 108. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 109. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 110. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 111. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 112. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 113. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 114. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 115. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 117. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 118. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 119. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 120. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 121. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 122. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 125. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 126. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 127. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: SCORES
  • TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: BUSINESS STRATEGY
  • TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: PRODUCT SATISFACTION
  • TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: RANKING
  • TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: SHARE, BY KEY PLAYER, 2021
  • TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: MERGER & ACQUISITION
  • TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: INVESTMENT & FUNDING
  • TABLE 137. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 138. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET: LICENSE & PRICING
目次
Product Code: MRR-501246436E44

The Global Artificial Intelligence In Genomics Market grew USD 1,717.49 million by 2027, at a CAGR of 32.23%.

The Global Artificial Intelligence In Genomics Market size was estimated at USD 321.23 million in 2021 and expected to reach USD 423.95 million in 2022, and is projected to grow at a CAGR 32.23% to reach USD 1,717.49 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Artificial Intelligence In Genomics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Offering, the market was studied across Services and Software.

Based on Technology, the market was studied across Computer Vision and Machine Learning.

Based on Functionality, the market was studied across Clinical Workflows, Gene Editing, Genome Sequencing, and Predictive Genetic Testing & Preventive Medicine.

Based on Application, the market was studied across Agriculture & animal Research, Diagnostics, Drug Discovery & Development, Other, and Precision Medicine.

Based on End User, the market was studied across Government Organizations, Healthcare Providers, Others, Pharmaceutical & Biotech Companies, and Research Centers, Academic Institutes, &.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Artificial Intelligence In Genomics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Intelligence In Genomics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Intelligence In Genomics Market, including BenevolentAI Ltd., Cambridge Cancer Genomics, Data4Cure Inc., Deep Genomics Inc., DNAnexus Inc., Eli Lilly and Company, Engine Biosciences Pte. Ltd., Fabric Genomics Inc., FDNA Inc., Freenome Holdings, Inc., Genoox Ltd., International Business Machines Corporation, Invitae Corporation, Lifebit Biotech, Microsoft Corporation, MolecularMatch, Inc., NVIDIA Corporation, PrecisionLife Ltd., SOPHiA GENETICS, and Verge Genomics.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Artificial Intelligence In Genomics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Intelligence In Genomics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence In Genomics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Artificial Intelligence In Genomics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Artificial Intelligence In Genomics Market?
  • 6. What is the market share of the leading vendors in the Global Artificial Intelligence In Genomics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Artificial Intelligence In Genomics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential demand attributed to drug discovery and drug developments
      • 5.1.1.2. Increasing expansions in pharmaceuticals and biotechnology industries associated with drug developments
      • 5.1.1.3. Ongoing investments in novel drug discoveries with genomic solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Absence of regulatory guidelines for utilization of AI in genomics
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adaptability of AI for clinical trials data management along with high-quality data generation
      • 5.1.3.2. Rising demand for advanced diagnostics methods due to emergence of novel diseases
      • 5.1.3.3. Upsurging governmental initiatives for AI deployment in genomics
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of skilled professionals associated with research and development
  • 5.2. Cumulative Impact of COVID-19

6. Artificial Intelligence In Genomics Market, by Offering

  • 6.1. Introduction
  • 6.2. Services
  • 6.3. Software

7. Artificial Intelligence In Genomics Market, by Technology

  • 7.1. Introduction
  • 7.2. Computer Vision
  • 7.3. Machine Learning

8. Artificial Intelligence In Genomics Market, by Functionality

  • 8.1. Introduction
  • 8.2. Clinical Workflows
  • 8.3. Gene Editing
  • 8.4. Genome Sequencing
  • 8.5. Predictive Genetic Testing & Preventive Medicine

9. Artificial Intelligence In Genomics Market, by Application

  • 9.1. Introduction
  • 9.2. Agriculture & animal Research
  • 9.3. Diagnostics
  • 9.4. Drug Discovery & Development
  • 9.5. Other
  • 9.6. Precision Medicine

10. Artificial Intelligence In Genomics Market, by End User

  • 10.1. Introduction
  • 10.2. Government Organizations
  • 10.3. Healthcare Providers
  • 10.4. Others
  • 10.5. Pharmaceutical & Biotech Companies
  • 10.6. Research Centers, Academic Institutes, &

11. Americas Artificial Intelligence In Genomics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Artificial Intelligence In Genomics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand

13. Europe, Middle East & Africa Artificial Intelligence In Genomics Market

  • 13.1. Introduction
  • 13.2. France
  • 13.3. Germany
  • 13.4. Italy
  • 13.5. Netherlands
  • 13.6. Qatar
  • 13.7. Russia
  • 13.8. Saudi Arabia
  • 13.9. South Africa
  • 13.10. Spain
  • 13.11. United Arab Emirates
  • 13.12. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
    • 14.1.1. Quadrants
    • 14.1.2. Business Strategy
    • 14.1.3. Product Satisfaction
  • 14.2. Market Ranking Analysis
  • 14.3. Market Share Analysis, By Key Player
  • 14.4. Competitive Scenario
    • 14.4.1. Merger & Acquisition
    • 14.4.2. Agreement, Collaboration, & Partnership
    • 14.4.3. New Product Launch & Enhancement
    • 14.4.4. Investment & Funding
    • 14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles

  • 15.1. BenevolentAI Ltd.
  • 15.2. Cambridge Cancer Genomics
  • 15.3. Data4Cure Inc.
  • 15.4. Deep Genomics Inc.
  • 15.5. DNAnexus Inc.
  • 15.6. Eli Lilly and Company
  • 15.7. Engine Biosciences Pte. Ltd.
  • 15.8. Fabric Genomics Inc.
  • 15.9. FDNA Inc.
  • 15.10. Freenome Holdings, Inc.
  • 15.11. Genoox Ltd.
  • 15.12. International Business Machines Corporation
  • 15.13. Invitae Corporation
  • 15.14. Lifebit Biotech
  • 15.15. Microsoft Corporation
  • 15.16. MolecularMatch, Inc.
  • 15.17. NVIDIA Corporation
  • 15.18. PrecisionLife Ltd.
  • 15.19. SOPHiA GENETICS
  • 15.20. Verge Genomics

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing